...
首页> 外文期刊>Journal of pain & palliative care pharmacotherapy >Desmoid Tumors: A Review of the Literature and Pharmacologic Management
【24h】

Desmoid Tumors: A Review of the Literature and Pharmacologic Management

机译:Desropoid肿瘤:对文献和药物管理的综述

获取原文
获取原文并翻译 | 示例
           

摘要

Desmoid tumors represent a nonmalignant proliferation of fibroblast-related cells. These rare tumors are difficult to treat and often persist as indolent, lifelong conditions. There are a number of treatments available for both anatomic and symptom regression. Some of these treatments, unfortunately, may not provide long-lasting results and may result in further complications. Pain is a distressing symptom that may be due to the tumor itself or the result of utilized treatments. Pharmacologic therapies represent a noninvasive alternative to surgical resection. Pain symptoms require therapeutic regimens that must be modified as the tumor evolves in expression. The individualized pain treatment program utilized may often reflect principles used in both nonmalignant and malignant pain management models. This review seeks to increase awareness of desmoid tumors through a review of the literature and discussion of its pharmacotherapeutic management.
机译:DeaMoid肿瘤代表了成纤维细胞的非正常增殖。 这些罕见的肿瘤难以治疗,并且通常持续存在惰性,终身的条件。 有许多治疗方法可用于解剖和症状回归。 遗憾的是,这些治疗中的一些可能无法提供持久的结果,并且可能导致进一步的并发症。 疼痛是一种令人痛苦的症状,可能是由于肿瘤本身或使用治疗的结果。 药理学疗法代表手术切除的非侵入性替代品。 疼痛症状需要治疗方案,因为肿瘤在表达中发展时必须修饰。 所使用的个性化疼痛治疗计划可能常常反映非开始和恶性疼痛管理模型中使用的原理。 该审查旨在通过审查其药物治疗管理的文献和讨论来提高对Desmoid肿瘤的认识。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号